Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

New Gene Therapy May Help Heart Attack Survivors
August 22, 2013

Researchers from the Gladstone Institutes in San Francisco found that injecting a therapy of genes into dead heart cells has promising implications for restarting the cells, based on studies done in mice and human cells in a lab. 

Scar tissue in heart ‘reprogrammed’
August 22, 2013

Gladstone researchers performed the feat using human cells in a laboratory dish.

Scientists Can Turn Scar Tissue Into Beating Human Heart Muscle
August 22, 2013

Researchers have found a way to genetically reprogram scar tissue in the heart to make it behave like muscle tissue.

Heart attack damage repaired using gene therapy
August 22, 2013

Scarred heart tissue can be transformed into beating cells using a cocktail of five genes, according to a new study.   

Scientists come closer to 'mending broken hearts'
August 22, 2013

Gladstone scientists have come a step closer to being able to repair the damage done by heart attacks, using a “cocktail of genes” to transform scar tissue into working heart muscles.

New Gene Therapy Approach May Regenerate Heart Muscle After A Heart Attack
August 22, 2013

Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.

Professor Helps Develop pE-MAP Technique That Allows Scientists To Predict Effect of Enzyme Mutations
August 12, 2013

A research team led by Nevan Krogan, PhD, of Gladstone Institutes and the University of California, San Francisco (UCSF); Craig Kaplan, PhD, of Texas A&M University; and Christine Guthrie, PhD, a UCSF Professor, has created a new technique called the point mutant E-MAP approach (pE-MAP) to predict how an enzyme behaves, and what happens when this process is disrupted, by mapping thousands of interactions among an enzyme’s many moving parts.

Acclaimed Molecular Biologist Named New QB3-UCSF Director
July 31, 2013

Gladstone Investigator Nevan Krogan, PhD, is named new director of the California Institute for Quantitative Biosciences (QB3).

HIV/AIDS: The Fight Isn't Over
July 25, 2013

Gladstone's Warner C. Greene, MD, PhD, explains in an op-ed why we must continue the fight against HIV/AIDS worldwide. 

The Rise of the Multi-Talented Adult Stem Cell
July 25, 2013

A new type of cell could lead to dramatic cures—and avoid ethical controversy. The Smithsonian's Virginia Hughes speaks to Gladstone stem cell scientist Dr. Deepak Srivastava.